S. 527, known as the "Prescription Pricing for the People Act of 2025," requires the Federal Trade Commission (FTC) to conduct a study on intermediaries in the pharmaceutical supply chain. The FTC must report to Congress on various issues such as pharmacy benefit manager...
Simple Explanation
The Prescription Pricing for the People Act of 2025 asks a group called the FTC to look at people in between who help get medicine from the makers to the stores, to see if they are being fair with prices. This group then has to tell the government what they find and suggest ways to make it better by making sure everyone is playing fair.